Relevance of the cytoplasmic accumulation of TDP-43 reported in the SOD1 mice—and its mitigation by treatment with CuII(atsm)—to ALS in humans is unclear. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.